Please login to the form below

ixabepilone

This page shows the latest ixabepilone news and features for those working in and with pharma, biotech and healthcare.

Bayer fails to overturn Nexavar compulsory licence in India

There have already been suggestions that Roche's breast cancer treatment Herceptin (trastuzumab) and Bristol-Myers Squibb's leukaemia medicine Sprycel (dasatinib) and chemotherapy Ixempra (ixabepilone) could follow Nexavar down this

Latest news

India could hit Roche and BMS with compulsory licences

Sprycel (dasatinib) and its chemotherapy Ixempra (ixabepilone).
Paclitaxel tops newer drugs in comparative breast cancer study

nab] paclitaxel) and 7.6 months with Bristol-Myers Squibb's Ixempra (ixabepilone) in the cohort of chemotherapy-naïve patients. ... Ixabepilone was significantly inferior to paclitaxel [and] nab-paclitaxel was not superior to paclitaxel in this
Triple negative breast cancer

One compound that works via this method is ixabepilone, which binds tubulin and promotes tubulin stabilisation whereby cell division cannot be completed. ... Bristol-Myers Squibb is also investigating ixabepilone in combination with cetuximab in the
Eisai wins approval for breast cancer drug

and with Bristol-Myers Squibb's Ixempra (ixabepilone), which is marketed for patients with late- stage disease after failure of an anthracycline, taxane and Xeloda.
Bristol-Myers signs cancer drug deal

BMS' existing cancer-drug portfolio includes Erbitux (cetuximab), Ixempra (ixabepilone) and Sprycel (dasatinib).

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest from PMHub

Endometrial Cancer Treatment Market Analysis, Segments, Growth and Value Chain 2017-2027

Chemotherapy. Carboplatin. Paclitaxel. Ixabepilone. Others. Hormonal Therapy. Megestrol (Megace). Medroxyprogesterone (PROVERA). ... Recent FDA approval of IXEMPRA (ixabepilone) for use in the treatment of endometrial cancer treatment is expected to fuel

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Account Manager – Creative Healthcare Advertising – Central Lond...: Salary TBC

Senior Systematic Review Analyst - Oxford: Negotiable

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

Director, Market Access / HEOR - North-West: Negotiable

Medical Writers Required – Cheshire: DOE

Associate Editorial Director – Med Comms – London: Salary TBC

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Senior Account Director development role to Business Director, H...: Excellent package

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Medical/ Scientific Director: Salary TBC

Digital Manager, London – Healthcare Brandcomms, Medcomms, PR: Excellent package

Production Manager – Healthcare Communications: DOE

Programme Director, Healthcare PR, Highly competitive package: Highly Competitive package

Medical Writers: Competitive Salary and Benefits

Project / Account Manager (Medical Education): Salary TBC

Account Director - Healthcare Advertising - London - HOME WORKIN...: £50000 - £68000

Scientific Director / Editorial Team Leader: Great salary and benefits

Senior Account Executive, London, Medical Communications: Excellent package

Senior Account Manager- Central Oxford and Abingdon: Negotiable

SAM – Health Behaviour/ Patient Adherence Healthcare Agency: Salary TBC

New Business Director - PR: Competitive Salary and benefits

Associate Medical Director: Highly Competitive

Associate Director, Market Access & HEOR – North-West: Negotiable

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Medical Writer – Health Behaviour/ Patient Adherence Agency: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...